<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">39384836</PMID><DateCompleted><Year>2024</Year><Month>10</Month><Day>09</Day></DateCompleted><DateRevised><Year>2024</Year><Month>10</Month><Day>13</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">2041-1723</ISSN><JournalIssue CitedMedium="Internet"><Volume>15</Volume><Issue>1</Issue><PubDate><Year>2024</Year><Month>Oct</Month><Day>10</Day></PubDate></JournalIssue><Title>Nature communications</Title><ISOAbbreviation>Nat Commun</ISOAbbreviation></Journal><ArticleTitle>Multi-scenario surveillance of respiratory viruses in aerosols with sub-single-copy spatial resolution.</ArticleTitle><Pagination><StartPage>8770</StartPage><MedlinePgn>8770</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">8770</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1038/s41467-024-53059-x</ELocationID><Abstract><AbstractText>Highly sensitive airborne virus monitoring is critical for preventing and containing epidemics. However, the detection of airborne viruses at ultra-low concentrations remains challenging due to the lack of ultra-sensitive methods and easy-to-deployment equipment. Here, we present an integrated microfluidic cartridge that can accurately detect SARS-COV-2, Influenza A, B, and respiratory syncytial virus with a sensitivity of 10 copies/mL. When integrated with a high-flow aerosol sampler, our microdevice can achieve a sub-single-copy spatial resolution of 0.83 copies/m<sup>3</sup> for airborne virus surveillance with an air flow rate of 400 L/min and a sampling time of 30 minutes. We then designed a series of virus-in-aerosols monitoring systems (RIAMs), including versions of a multi-site sampling RIAMs (M-RIAMs), a stationary real-time RIAMs (S-RIAMs), and a roaming real-time RIAMs (R-RIAMs) for different application scenarios. Using M-RIAMs, we performed a comprehensive evaluation of 210 environmental samples from COVID-19 patient wards, including 30 aerosol samples. The highest positive detection rate of aerosol samples (60%) proved the aerosol-based SARS-CoV-2 monitoring represents an effective method for spatial risk assessment. The detection of 78 aerosol samples in real-world settings via S-RIAMs confirmed its reliability for ultra-sensitive and continuous airborne virus monitoring. Therefore, RIAMs shows the potential as an effective solution for mitigating the risk of airborne virus transmission.</AbstractText><CopyrightInformation>© 2024. The Author(s).</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y" EqualContrib="Y"><LastName>Li</LastName><ForeName>Bao</ForeName><Initials>B</Initials><AffiliationInfo><Affiliation>School of Biomedical Engineering, Tsinghua University, Beijing, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Changping Laboratory, Beijing, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y" EqualContrib="Y"><LastName>Lin</LastName><ForeName>Baobao</ForeName><Initials>B</Initials><AffiliationInfo><Affiliation>School of Biomedical Engineering, Tsinghua University, Beijing, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y" EqualContrib="Y"><LastName>Wang</LastName><ForeName>Yan</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>Department of Infectious Diseases, Peking University First Hospital, Beijing, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y" EqualContrib="Y"><LastName>Shi</LastName><ForeName>Ye</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>School of Laboratory Medicine and Life Sciences, Wenzhou Medical University, Zhejiang, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zeng</LastName><ForeName>Wu</ForeName><Initials>W</Initials><AffiliationInfo><Affiliation>School of Biomedical Engineering, Tsinghua University, Beijing, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Changping Laboratory, Beijing, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zhao</LastName><ForeName>Yulan</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>Changping Laboratory, Beijing, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Gu</LastName><ForeName>Yin</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>State Key Laboratory of Space Medicine, China Astronaut Research and Training Center, Beijing, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Liu</LastName><ForeName>Chang</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>School of Biomedical Engineering, Tsinghua University, Beijing, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Gao</LastName><ForeName>Hui</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>Department of Infectious Diseases, Peking University First Hospital, Beijing, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Cheng</LastName><ForeName>Hao</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>Department of Infectious Diseases, Peking University First Hospital, Beijing, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zheng</LastName><ForeName>Xiaoqun</ForeName><Initials>X</Initials><AffiliationInfo><Affiliation>School of Laboratory Medicine and Life Sciences, Wenzhou Medical University, Zhejiang, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Xiang</LastName><ForeName>Guangxin</ForeName><Initials>G</Initials><Identifier Source="ORCID">0009-0007-2703-9035</Identifier><AffiliationInfo><Affiliation>School of Laboratory Medicine and Life Sciences, Wenzhou Medical University, Zhejiang, China. xiangguangxinwmu@qq.com.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wang</LastName><ForeName>Guiqiang</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>Department of Infectious Diseases, Peking University First Hospital, Beijing, China. john131212@126.com.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Infectious Diseases, Peking University International Hospital, Beijing, China. john131212@126.com.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Beijing Key Laboratory of Hepatitis C and Immunotherapy for Liver Diseases, Beijing, China. john131212@126.com.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Liu</LastName><ForeName>Peng</ForeName><Initials>P</Initials><Identifier Source="ORCID">0000-0003-3000-3168</Identifier><AffiliationInfo><Affiliation>School of Biomedical Engineering, Tsinghua University, Beijing, China. pliu@tsinghua.edu.cn.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Changping Laboratory, Beijing, China. pliu@tsinghua.edu.cn.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>Grant No. 32001021</GrantID><Agency>National Natural Science Foundation of China (National Science Foundation of China)</Agency><Country /></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2024</Year><Month>10</Month><Day>10</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Nat Commun</MedlineTA><NlmUniqueID>101528555</NlmUniqueID><ISSNLinking>2041-1723</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D000336">Aerosols</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000086402" MajorTopicYN="Y">SARS-CoV-2</DescriptorName><QualifierName UI="Q000302" MajorTopicYN="N">isolation &amp; purification</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000086382" MajorTopicYN="Y">COVID-19</DescriptorName><QualifierName UI="Q000635" MajorTopicYN="N">transmission</QualifierName><QualifierName UI="Q000821" MajorTopicYN="N">virology</QualifierName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName><QualifierName UI="Q000517" MajorTopicYN="N">prevention &amp; control</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000336" MajorTopicYN="Y">Aerosols</DescriptorName><QualifierName UI="Q000032" MajorTopicYN="N">analysis</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000391" MajorTopicYN="N">Air Microbiology</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D009980" MajorTopicYN="N">Influenza A virus</DescriptorName><QualifierName UI="Q000302" MajorTopicYN="N">isolation &amp; purification</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D004784" MajorTopicYN="N">Environmental Monitoring</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="N">methods</QualifierName><QualifierName UI="Q000295" MajorTopicYN="N">instrumentation</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D012136" MajorTopicYN="N">Respiratory Syncytial Viruses</DescriptorName><QualifierName UI="Q000302" MajorTopicYN="N">isolation &amp; purification</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D009981" MajorTopicYN="N">Influenza B virus</DescriptorName><QualifierName UI="Q000302" MajorTopicYN="N">isolation &amp; purification</QualifierName></MeshHeading></MeshHeadingList><CoiStatement>The authors declare no competing interests.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2024</Year><Month>3</Month><Day>25</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2024</Year><Month>9</Month><Day>26</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2024</Year><Month>10</Month><Day>10</Day><Hour>0</Hour><Minute>39</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2024</Year><Month>10</Month><Day>10</Day><Hour>0</Hour><Minute>38</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2024</Year><Month>10</Month><Day>9</Day><Hour>23</Hour><Minute>39</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2024</Year><Month>10</Month><Day>10</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">39384836</ArticleId><ArticleId IdType="pmc">PMC11464689</ArticleId><ArticleId IdType="doi">10.1038/s41467-024-53059-x</ArticleId><ArticleId IdType="pii">10.1038/s41467-024-53059-x</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Zhu, N. et al. A novel coronavirus from patients with pneumonia in China, 2019. N. Engl. J. Med.382, 727–733 (2020).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7092803</ArticleId><ArticleId IdType="pubmed">31978945</ArticleId></ArticleIdList></Reference><Reference><Citation>Hsiang, S. et al. The effect of large-scale anti-contagion policies on the COVID-19 pandemic. Nature584, 262–267 (2020).</Citation><ArticleIdList><ArticleId IdType="pubmed">32512578</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang, C. C. et al. Airborne transmission of respiratory viruses. Science373, eabd9149 (2021).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8721651</ArticleId><ArticleId IdType="pubmed">34446582</ArticleId></ArticleIdList></Reference><Reference><Citation>Greenhalgh, T. et al. Ten scientific reasons in support of airborne transmission of SARS-CoV-2. Lancet397, 1603–1605 (2021).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8049599</ArticleId><ArticleId IdType="pubmed">33865497</ArticleId></ArticleIdList></Reference><Reference><Citation>Stadnytskyi, V., Bax, C. E., Bax, A. &amp; Anfinrud, P. The airborne lifetime of small speech droplets and their potential importance in SARS-CoV-2 transmission. Proc. Natl. Acad. Sci.117, 11875–11877 (2020).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7275719</ArticleId><ArticleId IdType="pubmed">32404416</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu, Y. et al. Aerodynamic analysis of SARS-CoV-2 in two Wuhan hospitals. Nature582, 557–560 (2020).</Citation><ArticleIdList><ArticleId IdType="pubmed">32340022</ArticleId></ArticleIdList></Reference><Reference><Citation>Jaumdally, S. et al. Frequency, kinetics and determinants of viable SARS-CoV-2 in bioaerosols from ambulatory COVID-19 patients infected with the Beta, Delta or Omicron variants. Nat. Commun.15, 2003 (2024).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10914788</ArticleId><ArticleId IdType="pubmed">38443359</ArticleId></ArticleIdList></Reference><Reference><Citation>Setti, L. et al. Airborne transmission route of COVID-19: why 2 meters/6 feet of inter-personal distance could not be enough. Int. J. Environ. Res. Public. Health17, 2932 (2020).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7215485</ArticleId><ArticleId IdType="pubmed">32340347</ArticleId></ArticleIdList></Reference><Reference><Citation>Van Doremalen, N. et al. Aerosol and surface stability of SARS-CoV-2 as compared with SARS-CoV-1. N. Engl. J. Med.382, 1564–1567 (2020).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7121658</ArticleId><ArticleId IdType="pubmed">32182409</ArticleId></ArticleIdList></Reference><Reference><Citation>Rechsteiner, J. &amp; Winkler, K. C. Inactivation of respiratory syncytial virus in aerosol. J. Gen. Virol.5, 405–410 (1969).</Citation></Reference><Reference><Citation>Weber, T. P. &amp; Stilianakis, N. I. Inactivation of influenza A viruses in the environment and modes of transmission: a critical review. J. Infect.57, 361–373 (2008).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7112701</ArticleId><ArticleId IdType="pubmed">18848358</ArticleId></ArticleIdList></Reference><Reference><Citation>Loosli, C. G., Lemon, H. M., Robertson, O. H. &amp; Appel, E. Experimental air-borne influenza infection. I. Influence of humidity on survival of virus in air. Exp. Biol. Med.53, 205–206 (1943).</Citation></Reference><Reference><Citation>Chia, P. Y. et al. Detection of air and surface contamination by SARS-CoV-2 in hospital rooms of infected patients. Nat. Commun.11, 2800 (2020).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7260225</ArticleId><ArticleId IdType="pubmed">32472043</ArticleId></ArticleIdList></Reference><Reference><Citation>Raymenants, J. et al. Indoor air surveillance and factors associated with respiratory pathogen detection in community settings in Belgium. Nat. Commun.14, 1332 (2023).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10005919</ArticleId><ArticleId IdType="pubmed">36898982</ArticleId></ArticleIdList></Reference><Reference><Citation>Moriarty, L. F. et al. Public health responses to COVID-19 outbreaks on cruise ships—worldwide, February–March 2020. MMWR. Morb. Mortal. Wkly. Rep.69, 347–352 (2020).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7725517</ArticleId><ArticleId IdType="pubmed">32214086</ArticleId></ArticleIdList></Reference><Reference><Citation>Hadei, M. et al. Presence of SARS-CoV-2 in the air of public places and transportation. Atmos. Pollut. Res.12, 302–306 (2021).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7833664</ArticleId><ArticleId IdType="pubmed">33519256</ArticleId></ArticleIdList></Reference><Reference><Citation>Ramuta, M. D. et al. SARS-CoV-2 and other respiratory pathogens are detected in continuous air samples from congregate settings. Nat. Commun.13, 4717 (2022).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9366802</ArticleId><ArticleId IdType="pubmed">35953484</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang, X. et al. Monitoring SARS-CoV-2 in air and on surfaces and estimating infection risk in buildings and buses on a university campus. J. Exposure Sci. Environ. Epidemiol.32, 751–758 (2022).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9045468</ArticleId><ArticleId IdType="pubmed">35477766</ArticleId></ArticleIdList></Reference><Reference><Citation>Miller, S. L. et al. Transmission of SARS‐CoV‐2 by inhalation of respiratory aerosol in the Skagit Valley Chorale superspreading event. Indoor Air31, 314–323 (2021).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7537089</ArticleId><ArticleId IdType="pubmed">32979298</ArticleId></ArticleIdList></Reference><Reference><Citation>Shen, Y. et al. Community outbreak investigation of SARS-CoV-2 transmission among bus riders in eastern China. JAMA Intern. Med.180, 1665 (2020).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7489377</ArticleId><ArticleId IdType="pubmed">32870239</ArticleId></ArticleIdList></Reference><Reference><Citation>Qiu, G. et al. On-site airborne pathogen detection for infection risk mitigation. Chem. Soc. Rev.52, 8531–8579 (2023).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10712221</ArticleId><ArticleId IdType="pubmed">37882143</ArticleId></ArticleIdList></Reference><Reference><Citation>Morawska, L. &amp; Milton, D. K. It is time to address airborne transmission of coronavirus disease 2019 (COVID-19). Clin. Infect. Dis.71, 2311–2313 (2020).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7454469</ArticleId><ArticleId IdType="pubmed">32628269</ArticleId></ArticleIdList></Reference><Reference><Citation>Rahmani, A. R., Leili, M., Azarian, G. &amp; Poormohammadi, A. Sampling and detection of corona viruses in air: A mini review. Sci. Total Environ.740, 140207 (2020).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7295527</ArticleId><ArticleId IdType="pubmed">32554029</ArticleId></ArticleIdList></Reference><Reference><Citation>Rastmanesh, A., Boruah, J. S., Lee, M.-S. &amp; Park, S. On-Site Bioaerosol Sampling and Airborne Microorganism Detection Technologies. Biosensors14, 122 (2024).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10968652</ArticleId><ArticleId IdType="pubmed">38534229</ArticleId></ArticleIdList></Reference><Reference><Citation>Hu, X. et al. Evaluation of the clinical performance of single-, dual-, and triple-target SARS-CoV-2 RT-qPCR methods. Clin. Chim. Acta511, 143–148 (2020).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7550050</ArticleId><ArticleId IdType="pubmed">33058839</ArticleId></ArticleIdList></Reference><Reference><Citation>Puthussery, J. V. et al. Real-time environmental surveillance of SARS-CoV-2 aerosols. Nat. Commun.14, 3692 (2023).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10333287</ArticleId><ArticleId IdType="pubmed">37429842</ArticleId></ArticleIdList></Reference><Reference><Citation>Cho, Y. S. et al. Continuous surveillance of bioaerosols on-site using an automated bioaerosol-monitoring system. ACS Sens.5, 395–403 (2020).</Citation><ArticleIdList><ArticleId IdType="pubmed">31913022</ArticleId></ArticleIdList></Reference><Reference><Citation>Heo, K. J., Ko, H. S., Jeong, S. B., Kim, S. B. &amp; Jung, J. H. Enriched aerosol-to-hydrosol transfer for rapid and continuous monitoring of bioaerosols. Nano Lett21, 1017–1024 (2021).</Citation><ArticleIdList><ArticleId IdType="pubmed">33444028</ArticleId></ArticleIdList></Reference><Reference><Citation>Lee, I. et al. Integrated bioaerosol sampling/monitoring platform: field-deployable and rapid detection of airborne viruses. ACS Sens.5, 3915–3922 (2020).</Citation><ArticleIdList><ArticleId IdType="pubmed">33090778</ArticleId></ArticleIdList></Reference><Reference><Citation>Li, S. et al. An ultrasensitive and rapid “sample-to-answer” microsystem for on-site monitoring of SARS-CoV-2 in aerosols using “in situ” tetra-primer recombinase polymerase amplification. Biosens. Bioelectron.219, 114816 (2023).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9610180</ArticleId><ArticleId IdType="pubmed">36327559</ArticleId></ArticleIdList></Reference><Reference><Citation>Gu, Y. et al. Modular-based integrated microsystem with multiple sample preparation modules for automated forensic DNA typing from reference to challenging samples. Anal. Chem.91, 7435–7443 (2019).</Citation><ArticleIdList><ArticleId IdType="pubmed">31050401</ArticleId></ArticleIdList></Reference><Reference><Citation>Gan, W. et al. Chitosan-modified filter paper for nucleic acid extraction and “ in situ PCR” on a thermoplastic microchip. Anal. Chem.89, 3568–3575 (2017).</Citation><ArticleIdList><ArticleId IdType="pubmed">28230980</ArticleId></ArticleIdList></Reference><Reference><Citation>Emaus, M. N. et al. Nucleic acid extraction: fundamentals of sample preparation methodologies, current advancements, and future endeavors. Trac Trends Anal. Chem.130, 115985 (2020).</Citation></Reference><Reference><Citation>Geng, Z., Gu, Y., Li, S., Lin, B. &amp; Liu, P. A fully integrated in vitro diagnostic microsystem for pathogen detection developed using a “3d extensible” microfluidic design paradigm. Micromachines10, 873 (2019).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6953088</ArticleId><ArticleId IdType="pubmed">31842384</ArticleId></ArticleIdList></Reference><Reference><Citation>Geng, Z. et al. “Sample-to-answer” detection of rare ctDNA mutation from 2 mL plasma with a fully integrated DNA extraction and digital droplet PCR microdevice for liquid biopsy. Anal. Chem.92, 7240–7248 (2020).</Citation><ArticleIdList><ArticleId IdType="pubmed">32323972</ArticleId></ArticleIdList></Reference><Reference><Citation>Lin, B. et al. Needle‐Plug/Piston‐Based Modular Mesoscopic Design Paradigm Coupled With Microfluidic Device for Point‐of‐Care Pooled Testing. Adv. Sci. 2406076. 10.1002/advs.202406076 (2024).</Citation><ArticleIdList><ArticleId IdType="pubmed">39269286</ArticleId></ArticleIdList></Reference><Reference><Citation>Li, X. et al. A robot assisted high-flow portable cyclone sampler for bacterial and SARS-CoV-2 aerosols. Aerosol Air Qual. Res.21, 210130 (2021).</Citation></Reference><Reference><Citation>Mainelis, G. Bioaerosol sampling: classical approaches, advances, and perspectives. Aerosol Sci. Tech.54, 496–519 (2020).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9344602</ArticleId><ArticleId IdType="pubmed">35923417</ArticleId></ArticleIdList></Reference><Reference><Citation>Santarpia, J. L. et al. The size and culturability of patient-generated SARS-CoV-2 aerosol. J. Expo. Sci. Environ. Epidemiol.32, 706–711 (2022).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8372686</ArticleId><ArticleId IdType="pubmed">34408261</ArticleId></ArticleIdList></Reference><Reference><Citation>Stern, R. A. et al. Characterization of hospital airborne SARS-CoV-2. Respir. Res.22, 73 (2021).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7909372</ArticleId><ArticleId IdType="pubmed">33637076</ArticleId></ArticleIdList></Reference><Reference><Citation>Birgand, G. et al. Assessment of air contamination by SARS-CoV-2 in hospital settings. JAMA Netw. Open.3, e2033232 (2020).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7758808</ArticleId><ArticleId IdType="pubmed">33355679</ArticleId></ArticleIdList></Reference><Reference><Citation>Buonanno, G. et al. Link between SARS-CoV-2 emissions and airborne concentrations: closing the gap in understanding. J. Hazard. Mater.428, 128279 (2022).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8760841</ArticleId><ArticleId IdType="pubmed">35063838</ArticleId></ArticleIdList></Reference><Reference><Citation>Stern, R. A., Al-Hemoud, A., Alahmad, B. &amp; Koutrakis, P. Levels and particle size distribution of airborne SARS-CoV-2 at a healthcare facility in Kuwait. Sci. Total Environ.782, 146799 (2021).</Citation></Reference><Reference><Citation>Zhou, L. et al. Breath-, air- and surface-borne SARS-CoV-2 in hospitals. J. Aerosol Sci.152, 105693 (2021).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7557302</ArticleId><ArticleId IdType="pubmed">33078030</ArticleId></ArticleIdList></Reference><Reference><Citation>Ang, A. X. et al. Airborne SARS‐CoV‐2 surveillance in hospital environment using high‐flowrate air samplers and its comparison to surface sampling. Indoor Air32 (2022).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8653264</ArticleId><ArticleId IdType="pubmed">34519380</ArticleId></ArticleIdList></Reference><Reference><Citation>He, X. et al. Clinical symptom differences between mild and severe COVID-19 patients in China: a meta-analysis. Front. Public Health8, 561264 (2021).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7841395</ArticleId><ArticleId IdType="pubmed">33520906</ArticleId></ArticleIdList></Reference><Reference><Citation>Song, J.-W. et al. Immunological and inflammatory profiles in mild and severe cases of COVID-19. Nat. Commun.11, 3410 (2020).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7343781</ArticleId><ArticleId IdType="pubmed">32641700</ArticleId></ArticleIdList></Reference><Reference><Citation>Karron, R. A. Preventing respiratory syncytial virus (RSV) disease in children. Science372, 686–687 (2021).</Citation><ArticleIdList><ArticleId IdType="pubmed">33986169</ArticleId></ArticleIdList></Reference><Reference><Citation>Luhung, I. et al. Experimental parameters defining ultra-low biomass bioaerosol analysis. npj Biofilms Microbiomes7, 37 (2021).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8052325</ArticleId><ArticleId IdType="pubmed">33863892</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle>